Literature DB >> 7646356

Epitope mapping of dengue 1 virus E glycoprotein using monoclonal antibodies.

E Simantini1, K Banerjee.   

Abstract

Ten monoclonal antibodies (MAbs) were raised against dengue 1 (DEN 1, Hawaii) virus E glycoprotein. Specificity of the MAbs was tested by ELISA and immunofluorescence. Eight were DEN 1 type-specific, one was DEN group-reactive (DGR) and one was flavivirus cross-reactive (FCR). Two of these type specific MAbs exhibited haemagglutination-inhibition (HI) and neutralized (N) DEN 1 virus in vivo (HS). These two MAbs showed 100% protection against a challenge of 100 LD50 of DEN 1 virus in adult Swiss albino mice. The remaining six MAbs were HI negative, N negative and non-protective against challenge (NHS). Of these only three were reactive in the CF test. The DGR, FCR and one of the NHS MAbs (NHS-3) did not react with DEN 1 virus grown in Vero cells, whereas they reacted with DEN 1 virus grown in LLC-MK2 and C6/36 cells in immunofluorescence, probably indicating a difference in the synthesis/processing of viral proteins in these different cell lines. An epitope map of the E gp was drawn using a computer programme based on the additivity index values. The epitope map delineated five domains, a) S-I representing type-specific, HI positive, N positive and protecting MAbs. b) S-II representing type-specific, HI negative, N negative MAbs. c) S-III representing type-specific HI/N negative MAb, but distinct from S-II. d) DGR representing HI/N negative DEN group reactive MAb. e) FCR representing HI/N negative flavivirus cross-reactive MAb. Epitope analysis of a number of different DEN 1 strains isolated in India over a period of 30 years showed that the domains S-II and S-III which react with HI negative, DEN-1 specific MAbs were variable. The DGR domain and the S-I domains were conserved.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7646356     DOI: 10.1007/bf01322751

Source DB:  PubMed          Journal:  Arch Virol        ISSN: 0304-8608            Impact factor:   2.574


  33 in total

1.  Synthetic peptides derived from the deduced amino acid sequence of the E-glycoprotein of Murray Valley encephalitis virus elicit antiviral antibody.

Authors:  J T Roehrig; A R Hunt; A J Johnson; R A Hawkes
Journal:  Virology       Date:  1989-07       Impact factor: 3.616

2.  Antigenic structure of the flavivirus envelope protein E at the molecular level, using tick-borne encephalitis virus as a model.

Authors:  C W Mandl; F Guirakhoo; H Holzmann; F X Heinz; C Kunz
Journal:  J Virol       Date:  1989-02       Impact factor: 5.103

3.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

4.  Antigen capture ELISA for the identification of dengue viruses.

Authors:  G Kuno; D J Gubler; N S Santiago de Weil
Journal:  J Virol Methods       Date:  1985-10       Impact factor: 2.014

5.  A topological and functional model of epitopes on the structural glycoprotein of tick-borne encephalitis virus defined by monoclonal antibodies.

Authors:  F X Heinz; R Berger; W Tuma; C Kunz
Journal:  Virology       Date:  1983-04-30       Impact factor: 3.616

6.  Genetic variation among dengue 2 viruses of different geographic origin.

Authors:  D W Trent; J A Grant; L Rosen; T P Monath
Journal:  Virology       Date:  1983-07-30       Impact factor: 3.616

7.  Dengue virus-specific and flavivirus group determinants identified with monoclonal antibodies by indirect immunofluorescence.

Authors:  E A Henchal; M K Gentry; J M McCown; W E Brandt
Journal:  Am J Trop Med Hyg       Date:  1982-07       Impact factor: 2.345

8.  Dengue-1 virus envelope glycoprotein gene expressed in recombinant baculovirus elicits virus-neutralizing antibody in mice and protects them from virus challenge.

Authors:  R Putnak; R Feighny; J Burrous; M Cochran; C Hackett; G Smith; C Hoke
Journal:  Am J Trop Med Hyg       Date:  1991-08       Impact factor: 2.345

9.  Analysis of computer-predicted antibody inducing epitope on Japanese encephalitis virus.

Authors:  M Kutubuddin; M M Gore; K Banerjee; S N Ghosh; A S Kolaskar
Journal:  Acta Virol       Date:  1993-12       Impact factor: 1.162

10.  Antibodies to dengue 2 virus E-glycoprotein synthetic peptides identify antigenic conformation.

Authors:  J T Roehrig; A J Johnson; A R Hunt; R A Bolin; M C Chu
Journal:  Virology       Date:  1990-08       Impact factor: 3.616

View more
  3 in total

1.  The development of therapeutic antibodies that neutralize homologous and heterologous genotypes of dengue virus type 1.

Authors:  Bimmi Shrestha; James D Brien; Soila Sukupolvi-Petty; S Kyle Austin; Melissa A Edeling; Taekyung Kim; Katie M O'Brien; Christopher A Nelson; Syd Johnson; Daved H Fremont; Michael S Diamond
Journal:  PLoS Pathog       Date:  2010-04-01       Impact factor: 6.823

2.  Characterization and epitope mapping of Dengue virus type 1 specific monoclonal antibodies.

Authors:  Wen-Hung Chen; Feng-Pai Chou; Yu-Kuo Wang; Sheng-Cih Huang; Chuan-Hung Cheng; Tung-Kung Wu
Journal:  Virol J       Date:  2017-10-02       Impact factor: 4.099

3.  Alanine Substitution Inactivates Cross-Reacting Epitopes in Dengue Virus Recombinant Envelope Proteins.

Authors:  Viviana C Zomosa-Signoret; Karina R Morales-González; Ana E Estrada-Rodríguez; Ana M Rivas-Estilla; M Cristina Devèze-García; Edgar Galaviz-Aguilar; Román Vidaltamayo
Journal:  Viruses       Date:  2020-02-13       Impact factor: 5.048

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.